It is reasonable to think that PKM2 inhibition may also attenuate the progression of the pathogenesis not only of RA but also of OA, as PKM2 overexpression controls glycolysis and extracellular matrix dynamic in chondrocytes [84]. The gene discussed is PKM; the disease is rheumatoid arthritis.